Willis N Dabbs, MD in Oxford, MS - Medicare Family Practice

Willis N Dabbs, MD is a medicare enrolled "Family Medicine" physician in Oxford, Mississippi. He went to University Of Mississippi School Of Medicine and graduated in 2002 and has 22 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Urgent Care Clinic Of Oxford and his current practice location is 1487 Belk Blvd, Oxford, Mississippi. You can reach out to his office (for appointments etc.) via phone at (662) 234-1090.

Willis N Dabbs is licensed to practice in Mississippi (license number 18438) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1063528750.

Contact Information

	Willis N Dabbs, MD
	1487 Belk Blvd, Oxford, MS 38655-5371
	(662) 234-1090
	(662) 234-0432

Physician's Profile

Full Name	Willis N Dabbs
Gender	Male
Speciality	Family Practice
Experience	22 Years
Location	1487 Belk Blvd, Oxford, Mississippi
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Willis N Dabbs attended and graduated from University Of Mississippi School Of Medicine in 2002

NPI Data:

NPI Number: 1063528750
Provider Enumeration Date: 08/22/2006
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 5092755959
Enrollment ID: I20050510000661

Medical Identifiers

Medical identifiers for Willis N Dabbs such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1063528750	NPI	-	NPPES
06759064	Medicaid	MS

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	18438 (Mississippi)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Urgent Care Clinic Of Oxford	9537109491	6

News Archive

Trial shows which brain cancer patients benefit from temozolomide

An international team of scientists and cancer specialists has identified which patients with the deadly form of brain tumours called glioblastomas are likely to live longer if they are treated with temozolomide, and which patients are likely to get only marginal, if any, benefit.

avVaa World Health Care Products to launch third Direct TV Media Test

avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced their third Direct TV Media Test is scheduled to launch on Thursday October 29.

Global Fund reports mid-year results

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday announced that programs it supports have distributed 190 million insecticide-treated bed nets to protect families from malaria since 2003, according to mid-year results, a Global Fund press release notes.

Novartis announces FDA approval of Entresto to reduce risk of cardiovascular death, heart failure hospitalization

Novartis announced today that the US Food and Drug Administration has approved Entresto™ tablets, previously known as LCZ696, to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure and reduced ejection fraction.

Sandia researchers develop SpinDx medical diagnostic tool

Researchers at Sandia National Laboratories have developed a lab-on-a-disk platform that they believe will be faster, less expensive and more versatile than similar medical diagnostic tools.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Willis N Dabbs allows following entities to bill medicare on his behalf.

Entity Name	Urgent Care Clinic Of Oxford
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1043421357 PECOS PAC ID: 9537109491 Enrollment ID: O20110221000323

News Archive

Trial shows which brain cancer patients benefit from temozolomide

avVaa World Health Care Products to launch third Direct TV Media Test

Global Fund reports mid-year results

Novartis announces FDA approval of Entresto to reduce risk of cardiovascular death, heart failure hospitalization

Sandia researchers develop SpinDx medical diagnostic tool

Researchers at Sandia National Laboratories have developed a lab-on-a-disk platform that they believe will be faster, less expensive and more versatile than similar medical diagnostic tools.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Willis N Dabbs is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Willis N Dabbs, MD 1487 Belk Blvd, Oxford, MS 38655-5371 Ph: (662) 234-1090	Willis N Dabbs, MD 1487 Belk Blvd, Oxford, MS 38655-5371 Ph: (662) 234-1090

News Archive

Trial shows which brain cancer patients benefit from temozolomide

avVaa World Health Care Products to launch third Direct TV Media Test

Global Fund reports mid-year results

Novartis announces FDA approval of Entresto to reduce risk of cardiovascular death, heart failure hospitalization

Sandia researchers develop SpinDx medical diagnostic tool

Researchers at Sandia National Laboratories have developed a lab-on-a-disk platform that they believe will be faster, less expensive and more versatile than similar medical diagnostic tools.

Family Medicine Doctors in Oxford, MS

Eric Paul Dahl, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1487 Belk Blvd, Oxford, MS 38655 Phone: 662-234-1090 Fax: 662-234-0432
Shavonne Bridgette Doyle, NP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2908 S Lamar Blvd Ste 100, Oxford, MS 38655 Phone: 662-281-0112
Hunter Davis Haley, Family Medicine Medicare: Medicare Enrolled Practice Location: 497 Azalea Dr Ste 102, Oxford, MS 38655 Phone: 662-513-2000
Ana-maria Nae Benefield, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1397 Belk Blvd, Oxford, MS 38655 Phone: 622-236-4675
Shelly Renae-hughes Alamry, NP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2706 W Oxford Loop Ste 103, Oxford, MS 38655 Phone: 662-380-5445 Fax: 662-580-5517
Dr. Terri Jo Teague, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2173 S Lamar Blvd, Oxford, MS 38655 Phone: 662-234-6553

Willis N Dabbs, MD - Medicare Family Practice in Oxford, MS

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Trial shows which brain cancer patients benefit from temozolomide

avVaa World Health Care Products to launch third Direct TV Media Test

Global Fund reports mid-year results

Novartis announces FDA approval of Entresto to reduce risk of cardiovascular death, heart failure hospitalization

Sandia researchers develop SpinDx medical diagnostic tool

Medicare Reassignments

Trial shows which brain cancer patients benefit from temozolomide

avVaa World Health Care Products to launch third Direct TV Media Test

Global Fund reports mid-year results

Novartis announces FDA approval of Entresto to reduce risk of cardiovascular death, heart failure hospitalization

Sandia researchers develop SpinDx medical diagnostic tool

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Trial shows which brain cancer patients benefit from temozolomide

avVaa World Health Care Products to launch third Direct TV Media Test

Global Fund reports mid-year results

Novartis announces FDA approval of Entresto to reduce risk of cardiovascular death, heart failure hospitalization

Sandia researchers develop SpinDx medical diagnostic tool

Family Medicine Doctors in Oxford, MS